April 6, 2024 The first trial of a novel strategy for removing cholesterol from patients arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiologys Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.
C. Michael Gibson, MD
We did not see a statistically significant reduction in the primary endpoint of risk for death, a heart attack or a stroke at 90 days, or a reduction in risk for stroke at any time, said C. Michael Gibson, MD, a professor of medicine at Harvard Medical School and the studys lead author. However, in an exploratory analysis of outcomes, treated patients had fewer heart attacks and heart-attack deaths than patients in the control group at six months, he said.
Although we missed our primary endpoint, our data support the hypothesis that HDL cholesterol plays a role in reducing subsequent coronary plaque disruption events like heart attack via enhanced cholesterol efflux attacks, Gibson said.
People who have had a heart attack are at high risk for another one, especially during the next 90 days, Gibson said. This study was the first in which patients received an infusion of ApoA-I, a component of HDL (good) cholesterol, shortly after a heart attack, with the aim of stabilizing coronary plaque and reducing adverse cardiovascular events. The investigational drug CSL112 used in the study is a form of ApoA-I thats extracted from human plasma, the liquid component of blood.
High levels of LDL cholesterol create a build-up of plaque in the arteries that carry blood to the heart, increasing risk for an arterial blockage that causes a heart attack. HDL cholesterol removes cholesterol from the arteries and carries it to the liver, which then excretes it. ApoA-I, the main component of HDL cholesterol, helps initiate the process of removing cholesterol from the body. A previous study showed that a single infusion of CSL112 reduced the amount of LDL cholesterol in arterial plaque by as much as 50%.
Other studies have shown that high levels of HDL cholesterol are associated with reduced heart attack risk. Recent research, however, suggests that the level of HDL cholesterol number may be less important for reducing heart attack risk than how well it performs at removing cholesterol, Gibson said.
We know that in the setting of a heart attack, when the HDL cholesterol is good at getting a lot of cholesterol out of the arteries, that results in better outcomes for patients, he said.
Gibson and his colleagues hypothesized that infusions of CSL112 given shortly after a heart attack mightby boosting the bodys ability to dispose of cholesterolreduce patients risk for a repeat heart attack during the next crucial 90 days. The international AEGIS-II trial, conducted in 49 countries, was designed to test this hypothesis.
The study enrolled 18,219 patients (median age 65.5 years, 74% men and 84.5% White) who had been hospitalized for a heart attack and had multiple blockages in arteries carrying blood to the heart that elevated their risk for another heart attack. They also had other risk factors, including having had a previous heart attack, receiving drug treatment for diabetes or being 65 or older. Patients were randomly assigned to receive infusions of either CSL112 or a placebo for four weeks, with the first infusion given within five days of hospitalization.
The studys primary endpoint was the time to the first occurrence of a major adverse cardiovascular event (MACE; i.e., heart attack, stroke or death due to heart disease or a stroke) at 90 days. Secondary endpoints included the time to the first occurrence of a MACE within six months and one year and of each specific event within 90 days, six months and one year.
At 90 days, patients treated with CSL112 had a 4.8% reduction in risk for death, heart attack or stroke compared with 5.2% for those treated with a placebo, a difference that was not statistically significant. In an exploratory analysis, however, patients treated with CSL112 were 14% less likely to have or die from a heart attack at 180 days. In addition, patients treated with CSL112 were 32% less likely to have a heart attack caused by a blood clot in a stent (a tiny mesh tube inserted into an artery to prevent it from becoming blocked) at 90 days and 29% less likely at 180 days.
Another potentially important finding, Gibson said, is that patients whose LDL cholesterol level was 100 mg/dL or higher at study entry experienced a 30% decrease in the primary endpoint, a statistically significant finding, whereas patients whose LDL cholesterol at study entry was less than 100 mg/dL saw no decrease in the primary endpoint.
Baseline LDL modulated the treatment effect, Gibson said.
Overall, our findings are consistent with ApoA-I having a role in stabilizing heart blockages and reducing the risk of a blockage that ruptures and causing a heart attack further out than 90 days, Gibson said. Its plausible that by giving ApoA-1 to clear the cholesterol out of the body and then treating the patient with cholesterol-lowering medications to keep LDL cholesterol levels low, we could see reductions in deaths and heart attacks that continue over time.
Future research will focus on identifying high-risk patients who might benefit from this approach, he said. An antiplatelet effect of CSL112 or a reduction of cholesterol in the arteries resulting from treatment with CSL112 could also explain the significant reduction in the number of heart attacks caused by a blood clot in a stent, he said. The reason strokes were not reduced may be that strokes can be caused by mechanisms other than the rupture of arterial blockages, he said.
A limitation of the study is that women, Black people and people of Asian heritage were underrepresented, which could reduce the findings generalizability, Gibson said.
The study was funded by CSL Behring, the manufacturer of CSL112
This study was simultaneously published online in the New England Journal of Medicine at the time of presentation. The findings of the exploratory analysis were/will be published in the Journal of the American College of Cardiology, JACC.
Gibson presented the study, Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results, on Saturday, April 6, the first day of the ACC Scientific Session being held thru April 8 in Atlanta, GA.
For more information: http://www.acc.org
Find more ACC24 conference coverage here
See the rest here:
- Capital Cardiology Associates and CDPHP at odds over withheld payments - Times Union - March 30th, 2025 [March 30th, 2025]
- Mar 28, 2025 This Week in Cardiology Podcast - Medscape - March 30th, 2025 [March 30th, 2025]
- Green Spaces and Heart Health: A Natural Connection - The Cardiology Advisor - March 30th, 2025 [March 30th, 2025]
- Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting - Business Wire - March 30th, 2025 [March 30th, 2025]
- SA Asks: What are the best large-cap cardiology stocks right now? - Seeking Alpha - March 30th, 2025 [March 30th, 2025]
- Introducing New Cardiology Members - University of Utah School of Medicine - March 30th, 2025 [March 30th, 2025]
- SA Asks: Which cardiology drug companies could be takeout candidates? - Seeking Alpha - March 30th, 2025 [March 30th, 2025]
- Teams at Stormont Vail Hospital heard firsthand from a leading expert and researcher in cardiology - WIBW - March 30th, 2025 [March 30th, 2025]
- ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway - Business Wire - March 30th, 2025 [March 30th, 2025]
- CONNEQT Health Launches Industry-First Cardiology Report to Bring Clinical Heart Health Insights Home - Fitt Insider - March 30th, 2025 [March 30th, 2025]
- Indian Cardiology Market Size Trends and Forecast by Application, Type, and Geography, Opportunity Analysis - openPR - March 30th, 2025 [March 30th, 2025]
- What are the Health Benefits of the DASH Diet Plan? - Cardiology - Health Matters - March 15th, 2025 [March 15th, 2025]
- Mar 14, 2025 This Week in Cardiology Podcast - Medscape - March 15th, 2025 [March 15th, 2025]
- ECU Health offers remote healthcare access for cardiology patients - WNCT - March 15th, 2025 [March 15th, 2025]
- Powers Health cardiology experts support Hearts of Hope campaign, explore innovative treatments to improve patient lives at free community event -... - March 15th, 2025 [March 15th, 2025]
- Cardiology groups urge Congress to take a stand after spending proposal fails to fix Medicare cuts - Cardiovascular Business - March 15th, 2025 [March 15th, 2025]
- Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA Cardiology - PR... - March 15th, 2025 [March 15th, 2025]
- Broward Health Adds Pulsed Field Ablation Sytsem to Treat A-fib - Diagnostic and Interventional Cardiology - March 15th, 2025 [March 15th, 2025]
- Global Interventional Cardiology Devices Market Poised for Remarkable Growth, Set to Reach USD 36.9 Billion by 2032 | FMI FMIBlog - Future Market... - March 5th, 2025 [March 5th, 2025]
- MCCH earns cath lab accreditation by the American College of Cardiology - The Trib - March 5th, 2025 [March 5th, 2025]
- Feb 28, 2025 This Week in Cardiology Podcast - Medscape - March 5th, 2025 [March 5th, 2025]
- Ozempic and other GLP-1s are trending in Hollywood and cardiology departments - WGLT - March 5th, 2025 [March 5th, 2025]
- Detecting coronary inflammation on CT imaging could reshape preventive cardiology - Cardiovascular Business - March 5th, 2025 [March 5th, 2025]
- Global Surge in Heart Rhythm Disorders Sparks Call to Action - Diagnostic and Interventional Cardiology - March 5th, 2025 [March 5th, 2025]
- Fujifilm Expands Partnership with Hackensack Meridian Health Enabling Network-wide Use of State-of-the-Art Synapse Cardiology PACS Imaging System -... - March 5th, 2025 [March 5th, 2025]
- Behind the Walls of Cardiology: Where innovation meets compassion - Brunswick News - February 25th, 2025 [February 25th, 2025]
- Cardiology Team: Making a Difference in Your Heart - Southeast Georgia Health System - February 25th, 2025 [February 25th, 2025]
- Feb 21, 2025 This Week in Cardiology Podcast - Medscape - February 25th, 2025 [February 25th, 2025]
- Nuclear cardiology a nuclear perspective on matters of the heart - healthcare-in-europe.com - February 25th, 2025 [February 25th, 2025]
- Ionis Continues to Expand Its Cardiology and Neurology Portfolio, Supporting Narrow Moat - Morningstar - February 25th, 2025 [February 25th, 2025]
- Shenango Cardiology Consultants Affiliates with Meadville Medical - businessjournaldaily.com - February 25th, 2025 [February 25th, 2025]
- Author balances romance writing with cardiology insights - Turn to 10 - February 25th, 2025 [February 25th, 2025]
- Providing Health Care in Conflict Zones: A Neurosurgeons Mission to Gaza - The Cardiology Advisor - February 3rd, 2025 [February 3rd, 2025]
- Jan 31, 2025 This Week in Cardiology Podcast - Medscape - February 3rd, 2025 [February 3rd, 2025]
- At Least 60% of Americans To Have Heart Disease By 2050, According To Alarming Study Cardiology Experts Offer Tips To Know This Heart Month -... - February 3rd, 2025 [February 3rd, 2025]
- FMC column: Prioritize preventative cardiology during American Heart Month in February - Lancaster Eagle Gazette - February 3rd, 2025 [February 3rd, 2025]
- Interventional Cardiology Joins The Match for First Time - Medscape - January 23rd, 2025 [January 23rd, 2025]
- Akron Childrens teams with Cincinnati Childrens on pediatric cardiology care - Crain's Cleveland Business - January 23rd, 2025 [January 23rd, 2025]
- FDA regulator examines AI's growing influence in cardiology - Cardiovascular Business - January 23rd, 2025 [January 23rd, 2025]
- Jan 17, 2025 This Week in Cardiology Podcast - Medscape - January 23rd, 2025 [January 23rd, 2025]
- Jan 10, 2025 This Week in Cardiology Podcast - Medscape - January 15th, 2025 [January 15th, 2025]
- UC Davis Health cardiology team is one of the first in the nation to use novel pVAD system - UC Davis Health - January 15th, 2025 [January 15th, 2025]
- Bethesda Health Clinic Receives $15,000 Grant from American Heart Associations Circle of Red to Enhance Cardiology Services - Gilmer Mirror - January 15th, 2025 [January 15th, 2025]
- Top in cardiology: Antipsychotic drugs prolong severe QT; intermittent fasting and death - Healio - January 1st, 2025 [January 1st, 2025]
- ICYMI: 'Exploding in population': Nampa hospital expansion to bring needed NICU, cardiology space - boisedev.com - January 1st, 2025 [January 1st, 2025]
- Dec 20, 2024 This Week in Cardiology Podcast - Medscape - December 23rd, 2024 [December 23rd, 2024]
- Samuel Family Cardiology to open medical office in Spring - Community Impact - December 23rd, 2024 [December 23rd, 2024]
- Top in cardiology: Impact of added sugar source on CVD risk; SGLT2, GLP-1 use after stroke - Healio - December 23rd, 2024 [December 23rd, 2024]
- Researchers Find Drinking Coffee May Help Prevent Mental Decline in People with AFib - Diagnostic and Interventional Cardiology - December 23rd, 2024 [December 23rd, 2024]
- Narrow-Moat Ionis Is Expanding Its Neurology and Cardiology Portfolio to Strengthen Its Moat - Morningstar - December 9th, 2024 [December 9th, 2024]
- Shaping the Future of Cardiology: Key Takeaways From AHA 2024 - AJMC.com Managed Markets Network - November 28th, 2024 [November 28th, 2024]
- Jennifer DuMond Joins Cardiology Associates of Schenectady - SPHP News - November 28th, 2024 [November 28th, 2024]
- Nov 22, 2024 This Week in Cardiology Podcast - Medscape - November 28th, 2024 [November 28th, 2024]
- Fujifilm to Highlight the Speed of Synapse VX for Mammography and Cardiology, Cloud-Native Architecture and AI-Driven Workflows at RSNA 2024 - The... - November 28th, 2024 [November 28th, 2024]
- Director of Cardiology Research and Practical Centre: in many respects we keep pace with worlds largest clinics - - - November 28th, 2024 [November 28th, 2024]
- AI breakthrough in healthcare to revolutionize cardiology and more - Eyewitness News 3 - November 20th, 2024 [November 20th, 2024]
- Lehigh Valley Heart and Vascular Institute Welcomes Two Cardiology Specialists - Lehigh Valley Health Network - November 20th, 2024 [November 20th, 2024]
- Nov 15, 2024 This Week in Cardiology Podcast - Medscape - November 20th, 2024 [November 20th, 2024]
- Noblestitch Suture-Mediated PFO Closure Yields Zero Recurrent Strokes in the largest cohort with Four-Year Study presented at the TCT cardiology... - November 20th, 2024 [November 20th, 2024]
- Centra Health shifting cardiology services from Danville to Gretna - GoDanRiver.com - November 20th, 2024 [November 20th, 2024]
- Interventional Cardiology Devices Market to Reach $33.46 Billion by 2031, Growing at a 7.5% CAGR As Reveale... - WhaTech - November 20th, 2024 [November 20th, 2024]
- Dr. Kathleen A. Harper, MD is featured as a TOP INDUSTRY EXPERT Representing the Field of Cardiology for 2024 - EIN News - November 20th, 2024 [November 20th, 2024]
- 'Exploding in population': Nampa hospital expansion to bring needed NICU, cardiology space - boisedev.com - November 12th, 2024 [November 12th, 2024]
- Cardiology Diagnostics Market: Rapid Growth and Key Research - openPR - November 12th, 2024 [November 12th, 2024]
- Oct 25, 2024 This Week in Cardiology Podcast - Medscape - October 26th, 2024 [October 26th, 2024]
- Cardiology of Virginia patient data appears to be up for sale. Has the entity issued any statement at all? - DataBreaches.net - October 26th, 2024 [October 26th, 2024]
- Philips showcases next level cardiology innovations for improved patient care at TCT 2024 - Yahoo Finance - October 26th, 2024 [October 26th, 2024]
- Care Medical and Boston Scientific to enhance cardiology and urology care - Healthcare Asia - October 26th, 2024 [October 26th, 2024]
- Is Cardiology Overtreating Aortic Stenosis? with Linda Gillam, MD, MPH - MD Magazine - October 13th, 2024 [October 13th, 2024]
- Oct 11, 2024 This Week in Cardiology Podcast - Medscape - October 13th, 2024 [October 13th, 2024]
- The need for a personalized implementation hypertension strategy to facilitate the implementation of the new European Society of Hypertension (2023),... - October 13th, 2024 [October 13th, 2024]
- Cardiology Information System Market Size Expected To Grow At Around 8.6% CAGR During The Forecast Period - openPR - October 2nd, 2024 [October 2nd, 2024]
- OSF Medical Group in Alton Welcomes Second Cardiology Nurse Practitioner Mary Goetten - RiverBender.com - October 2nd, 2024 [October 2nd, 2024]
- Top in cardiology: Heart attacks spike after cold spells; Wegovy linked to CV benefits - Healio - October 2nd, 2024 [October 2nd, 2024]
- The Potential Risks of Lecanemab Use in Patients With High Cardiovascular Risk - The Cardiology Advisor - October 2nd, 2024 [October 2nd, 2024]
- $41,900.3+ Mn Interventional Cardiology and Peripheral Vascular Devices Market: Rising Demand and Growth - EIN News - October 2nd, 2024 [October 2nd, 2024]
- Central Pa. cardiology practice relocates one of its offices - PennLive - October 2nd, 2024 [October 2nd, 2024]
- Emerging Therapies in Interventional Cardiology - ETHealthWorld - October 2nd, 2024 [October 2nd, 2024]
- Sep 20, 2024 This Week in Cardiology Podcast - Medscape - September 23rd, 2024 [September 23rd, 2024]
- 'An exciting time': PCB medical office building adds cardiology and pulmonary services - The News Herald - September 23rd, 2024 [September 23rd, 2024]